Loss of p19(Arf) facilitates the angiogenic switch and tumor initiation in a multi-stage cancer model via p53-dependent and independent mechanisms.
The Arf tumor suppressor acts as a sensor of oncogenic signals, countering aberrant proliferation in large part via activation of the p53 transcriptional program, though a number of p53-independent functions have been described. Mounting evidence suggests that, in addition to promoting tumorigenesis...
Main Authors: | Danielle B Ulanet, Douglas Hanahan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-08-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2929208?pdf=render |
Similar Items
-
Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.
by: Sumaira Amir, et al.
Published: (2013-01-01) -
Inactivation of the p53/MDM2/p14ARF pathway in neuroblastoma
by: Carr-Wilkinson, Jane
Published: (2009) -
p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.
by: Karen S Kelly-Spratt, et al.
Published: (2004-08-01) -
Decreased Mdm2 expression inhibits tumor development and extends survival independent of Arf and dependent on p53.
by: Christine M Eischen, et al.
Published: (2012-01-01) -
Role of the Tumor Suppressor ARF and the p53-pathway in Retinoblastoma Development
by: To, Kwong Him
Published: (2009)